Lanadelumab in a kidney transplant patient with hereditary angioedema due to C1-inhibitor deficiency and high cardiovascular risk - a case report.

MLA

Gidaro, Antonio, et al. “Lanadelumab in a Kidney Transplant Patient with Hereditary Angioedema Due to C1-Inhibitor Deficiency and High Cardiovascular Risk - a Case Report.” Frontiers in Immunology, Nov. 2024, pp. 1–6. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1472390.

APA

Gidaro, A., La Cava, L., Donadoni, M., Janu, V. P., Cogliati, C., Brucato, A. L., Zanichelli, A., Cancian, M., & Bizzi, E. (2024). Lanadelumab in a kidney transplant patient with hereditary angioedema due to C1-inhibitor deficiency and high cardiovascular risk - a case report. Frontiers in Immunology, 1–6. https://doi.org/10.3389/fimmu.2024.1472390

Chicago

Gidaro, Antonio, Leyla La Cava, Mattia Donadoni, Valentina Popescu Janu, Chiara Cogliati, Antonio Luca Brucato, Andrea Zanichelli, Mauro Cancian, and Emanuele Bizzi. 2024. “Lanadelumab in a Kidney Transplant Patient with Hereditary Angioedema Due to C1-Inhibitor Deficiency and High Cardiovascular Risk - a Case Report.” Frontiers in Immunology, November, 1–6. doi:10.3389/fimmu.2024.1472390.